Timm Dirrichs Selected Research

Anticoagulants

4/2022

Influence of rivaroxaban compared to vitamin K antagonist treatment upon development of cardiovascular calcification in patients with atrial fibrillation and/or pulmonary embolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timm Dirrichs Research Topics

Disease

2	Tendinopathy (Tendonitis) 09/2021 - 01/2017
1	Atrial Fibrillation 04/2022
1	Pulmonary Embolism 04/2022
1	Plantar Fasciitis 08/2020
1	Lung Diseases (Lung Disease) 01/2020
1	Pain (Aches) 01/2020
1	Vascular Calcification 04/2016
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Shoulder Fractures 07/2013

Drug/Important Bio-Agent (IBA)

1	Warfarin (Coumadin)FDA LinkGeneric 04/2022
1	AnticoagulantsIBA 04/2022
1	RivaroxabanIBA 04/2022
1	Phenprocoumon (Liquamar)FDA Link 04/2022
1	Vitamin K FDA Link 04/2022
1	Peptides (Polypeptides)IBA 01/2020
1	Polidocanol (Laureth)FDA Link 01/2017
1	Anesthetics (Anesthetic Agents)IBA 01/2017
1	calcium phosphateIBA 07/2013

Therapy/Procedure

3	Therapeutics 04/2022 - 01/2017
1	Extracorporeal Shockwave Therapy 09/2021
1	Physical Therapy Modalities (Physical Therapy Technique) 08/2020
1	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2020
1	Muscle Stretching Exercises (Stretching, Static) 01/2017
1	Renal Dialysis (Hemodialysis) 04/2016
1	Drug Therapy (Chemotherapy) 08/2014